GLENMARK PHARMACEUTICALS Q2 FY27 (CONSOLIDATED)
β’ Net Profit βΉ263.83 Cr β56.78% YoY, β45.36% QoQ
β’ Revenue βΉ4,247.33 Cr β29.76% YoY, β5.69% QoQ
β’ EBITDA βΉ863.81 Cr β63.39% YoY, β7.33% QoQ
β’ Margins 20.34% vs 39.02% YoY, 20.03% QoQ
β’ Net Profit βΉ263.83 Cr β56.78% YoY, β45.36% QoQ
β’ Revenue βΉ4,247.33 Cr β29.76% YoY, β5.69% QoQ
β’ EBITDA βΉ863.81 Cr β63.39% YoY, β7.33% QoQ
β’ Margins 20.34% vs 39.02% YoY, 20.03% QoQ
JOST'S ENGINEERING Q2 FY27 β OK π±
β’ Net Profit: βΉ3 Cr | β309% YoY | β38% QoQ
β’ Revenue: βΉ44 Cr | β18% YoY | β15% QoQ
β’ EBITDA: βΉ3 Cr | β16% YoY | β1% QoQ
β’ EBITDA Margin: 7.9% vs 7.7% (YoY) | 6.8% (QoQ)
β’ Net Profit: βΉ3 Cr | β309% YoY | β38% QoQ
β’ Revenue: βΉ44 Cr | β18% YoY | β15% QoQ
β’ EBITDA: βΉ3 Cr | β16% YoY | β1% QoQ
β’ EBITDA Margin: 7.9% vs 7.7% (YoY) | 6.8% (QoQ)
ULTRAMARINE & PIGMENTS Q2 FY27 β OK π±
β’ Net Profit: βΉ29 Cr | β52% YoY | β7% QoQ
β’ Revenue: βΉ252 Cr | β28% YoY | β5% QoQ
β’ Operating Profit: βΉ45 Cr | β42% YoY | Flat QoQ
β’ Operating Profit Margin: 17.8% vs 16.1% (YoY) | 18.9% (QoQ)
β’ Other Income: βΉ3 Cr
β’ EPS: βΉ10.05 | β52% YoY | β7% QoQ
β’ Net Profit: βΉ29 Cr | β52% YoY | β7% QoQ
β’ Revenue: βΉ252 Cr | β28% YoY | β5% QoQ
β’ Operating Profit: βΉ45 Cr | β42% YoY | Flat QoQ
β’ Operating Profit Margin: 17.8% vs 16.1% (YoY) | 18.9% (QoQ)
β’ Other Income: βΉ3 Cr
β’ EPS: βΉ10.05 | β52% YoY | β7% QoQ
GLOBE ENTERPRISES Q2 FY27 β OK π±
β’ Net Profit: βΉ4 Cr | β15% YoY | β31% QoQ
β’ Revenue: βΉ210 Cr | β34% YoY | β14% QoQ
β’ EBITDA: βΉ11 Cr | β48% YoY | β19% QoQ
β’ EBITDA Margin: 5.3% vs 4.8% (YoY) | 5.0% (QoQ)
β’ Net Profit: βΉ4 Cr | β15% YoY | β31% QoQ
β’ Revenue: βΉ210 Cr | β34% YoY | β14% QoQ
β’ EBITDA: βΉ11 Cr | β48% YoY | β19% QoQ
β’ EBITDA Margin: 5.3% vs 4.8% (YoY) | 5.0% (QoQ)
JSL INDUSTRIES Q2 FY27 (STANDALONE) β GOOD β
β’ Net Profit: βΉ1 Cr | β18% YoY | β164% QoQ
β’ Revenue: βΉ17 Cr | β32% YoY | β20% QoQ
β’ EBITDA: βΉ1 Cr | β36% YoY | β169% QoQ
β’ EBITDA Margin: 8.6% vs 8.3% (YoY) | 3.8% (QoQ)
β’ Net Profit: βΉ1 Cr | β18% YoY | β164% QoQ
β’ Revenue: βΉ17 Cr | β32% YoY | β20% QoQ
β’ EBITDA: βΉ1 Cr | β36% YoY | β169% QoQ
β’ EBITDA Margin: 8.6% vs 8.3% (YoY) | 3.8% (QoQ)
INSECTICIDES INDIA Q2 FY27 β GOOD β
β’ Net Profit: βΉ56 Cr | β5% YoY | β28% QoQ
β’ Revenue: βΉ686 Cr | β8% YoY | β12% QoQ
β’ Operating Profit: βΉ92 Cr | β3% YoY | β37% QoQ
β’ Operating Profit Margin: 13.5% vs 14.0% (YoY) | 11.1% (QoQ)
β’ Other Income: -βΉ1 Cr
β’ EPS: βΉ19.30 | β5% YoY | β28% QoQ
β’ Net Profit: βΉ56 Cr | β5% YoY | β28% QoQ
β’ Revenue: βΉ686 Cr | β8% YoY | β12% QoQ
β’ Operating Profit: βΉ92 Cr | β3% YoY | β37% QoQ
β’ Operating Profit Margin: 13.5% vs 14.0% (YoY) | 11.1% (QoQ)
β’ Other Income: -βΉ1 Cr
β’ EPS: βΉ19.30 | β5% YoY | β28% QoQ
VA TECH WABAG Q2 FY27 (CONSOLIDATED) β EXCELLENT π
β’ Net Profit: βΉ104.60 Cr | β23.35% YoY | β16.09% QoQ
β’ Revenue: βΉ1,000.20 Cr | β19.86% YoY | β12.79% QoQ
β’ EBITDA: βΉ124.30 Cr | β39.19% YoY | β56.35% QoQ
β’ EBITDA Margin: 12.43% vs 10.70% (YoY) | 8.96% (QoQ)
β’ Net Profit: βΉ104.60 Cr | β23.35% YoY | β16.09% QoQ
β’ Revenue: βΉ1,000.20 Cr | β19.86% YoY | β12.79% QoQ
β’ EBITDA: βΉ124.30 Cr | β39.19% YoY | β56.35% QoQ
β’ EBITDA Margin: 12.43% vs 10.70% (YoY) | 8.96% (QoQ)
HBSL Q2 FY27 (CONSOLIDATED) β WEAK β οΈ
β’ Net Loss: βΉ3.29 Cr | Loss narrowed 28.51% YoY | Loss vs Profit (QoQ)
β’ Revenue: βΉ0.60 Cr | β46.24% YoY | β94.06% QoQ
β’ EBITDA Loss: βΉ3.19 Cr | Loss narrowed 34.64% YoY | β135.42% QoQ
β’ EBITDA Margin: -533.24% vs -1,193.12% (YoY) | 89.39% (QoQ)
β’ Net Loss: βΉ3.29 Cr | Loss narrowed 28.51% YoY | Loss vs Profit (QoQ)
β’ Revenue: βΉ0.60 Cr | β46.24% YoY | β94.06% QoQ
β’ EBITDA Loss: βΉ3.19 Cr | Loss narrowed 34.64% YoY | β135.42% QoQ
β’ EBITDA Margin: -533.24% vs -1,193.12% (YoY) | 89.39% (QoQ)
BHARTI AIRTEL Q2 FY27 (CONSOLIDATED) β GOOD β
β’ Net Profit: βΉ10,710 Cr | β24% YoY | β7% QoQ
β’ Revenue: βΉ60,877 Cr | β17% YoY | β4% QoQ
β’ EBITDA: βΉ35,055 Cr | β18% YoY | β5% QoQ
β’ EBITDA Margin: 57.58% vs 56.8% (YoY) | 57.07% (QoQ)
β’ Net Profit: βΉ10,710 Cr | β24% YoY | β7% QoQ
β’ Revenue: βΉ60,877 Cr | β17% YoY | β4% QoQ
β’ EBITDA: βΉ35,055 Cr | β18% YoY | β5% QoQ
β’ EBITDA Margin: 57.58% vs 56.8% (YoY) | 57.07% (QoQ)
β€3
GUJARAT INDUSTRIES POWER Q2 FY27 (STANDALONE) β GOOD β
β’ Net Profit: βΉ39 Cr | β84% YoY | β75% QoQ
β’ Revenue: βΉ431 Cr | β34% YoY | β14% QoQ
β’ EBITDA: βΉ173 Cr | β61% YoY | β28% QoQ
β’ EBITDA Margin: 40.2% vs 33.5% (YoY) | 48.4% (QoQ)
β’ Other Income: βΉ22 Cr
β’ EPS: βΉ2.53 | β85% YoY | β75% QoQ
β’ Net Profit: βΉ39 Cr | β84% YoY | β75% QoQ
β’ Revenue: βΉ431 Cr | β34% YoY | β14% QoQ
β’ EBITDA: βΉ173 Cr | β61% YoY | β28% QoQ
β’ EBITDA Margin: 40.2% vs 33.5% (YoY) | 48.4% (QoQ)
β’ Other Income: βΉ22 Cr
β’ EPS: βΉ2.53 | β85% YoY | β75% QoQ
AADHAR HOUSING FINANCE Q2 FY27 β OK π±
β’ Net Profit: βΉ308 Cr | β16% YoY | β9% QoQ
β’ Net Interest Income: βΉ536 Cr | β17% YoY | β5% QoQ
β’ Pre-Provision Operating Profit: βΉ397 Cr | β16% YoY | β9% QoQ
β’ Provisions: βΉ24 Cr | β84% YoY | β23% QoQ
β’ EPS: βΉ7.04
β’ Net Profit: βΉ308 Cr | β16% YoY | β9% QoQ
β’ Net Interest Income: βΉ536 Cr | β17% YoY | β5% QoQ
β’ Pre-Provision Operating Profit: βΉ397 Cr | β16% YoY | β9% QoQ
β’ Provisions: βΉ24 Cr | β84% YoY | β23% QoQ
β’ EPS: βΉ7.04
MAITHAN ALLOYS Q2 FY27 β OK π±
β’ Net Profit: βΉ84 Cr | β170% YoY | β79% QoQ
β’ Revenue: βΉ557 Cr | β13% YoY | β3% QoQ
β’ EBITDA: βΉ87 Cr | β170% YoY | β4% QoQ
β’ EBITDA Margin: 15.6% vs 6.5% (YoY) | 16.8% (QoQ)
β’ Other Income: -βΉ40 Cr
β’ EPS: βΉ27.85 | β167% YoY | β79% QoQ
β’ Net Profit: βΉ84 Cr | β170% YoY | β79% QoQ
β’ Revenue: βΉ557 Cr | β13% YoY | β3% QoQ
β’ EBITDA: βΉ87 Cr | β170% YoY | β4% QoQ
β’ EBITDA Margin: 15.6% vs 6.5% (YoY) | 16.8% (QoQ)
β’ Other Income: -βΉ40 Cr
β’ EPS: βΉ27.85 | β167% YoY | β79% QoQ
INDIA SHELTER FINANCE Q2 FY27 (STANDALONE) β OK π±
β’ Net Profit: βΉ146 Cr | β20% YoY | β2% QoQ
β’ Revenue: βΉ450 Cr | β22% YoY | β4% QoQ
β’ Operating Profit: βΉ320 Cr | β18% YoY | β3% QoQ
β’ Operating Profit Margin: 71.0% vs 73.3% (YoY) | 71.5% (QoQ)
β’ EPS: βΉ13.28
β’ Net Profit: βΉ146 Cr | β20% YoY | β2% QoQ
β’ Revenue: βΉ450 Cr | β22% YoY | β4% QoQ
β’ Operating Profit: βΉ320 Cr | β18% YoY | β3% QoQ
β’ Operating Profit Margin: 71.0% vs 73.3% (YoY) | 71.5% (QoQ)
β’ EPS: βΉ13.28
TCI EXPRESS Q2 FY27 β OK π±
β’ Net Profit: βΉ23 Cr | Flat YoY | β15% QoQ
β’ Revenue: βΉ338 Cr | β10% YoY | β8% QoQ
β’ EBITDA: βΉ36 Cr | β9% YoY | β16% QoQ
β’ EBITDA Margin: 10.8% vs 10.9% (YoY) | 10.0% (QoQ)
β’ Other Income: βΉ4 Cr
β’ EPS: βΉ5.74 | β8% YoY | β10% QoQ
β’ Net Profit: βΉ23 Cr | Flat YoY | β15% QoQ
β’ Revenue: βΉ338 Cr | β10% YoY | β8% QoQ
β’ EBITDA: βΉ36 Cr | β9% YoY | β16% QoQ
β’ EBITDA Margin: 10.8% vs 10.9% (YoY) | 10.0% (QoQ)
β’ Other Income: βΉ4 Cr
β’ EPS: βΉ5.74 | β8% YoY | β10% QoQ
SIGNATUREGLOBAL Q2 FY27 β GOOD β
β’ Net Profit: βΉ67 Cr | β243% YoY | β505% QoQ
β’ Revenue: βΉ817 Cr | β141% YoY | β48% QoQ
β’ EBITDA: βΉ76 Cr vs Loss of βΉ74 Cr (YoY) | vs Loss of βΉ45 Cr (QoQ)
β’ EBITDA Margin: 9.2% vs -22.0% (YoY) | -8.1% (QoQ)
β’ Other Income: βΉ53 Cr
β’ EPS: βΉ4.76 | β243% YoY | β503% QoQ
β’ Net Profit: βΉ67 Cr | β243% YoY | β505% QoQ
β’ Revenue: βΉ817 Cr | β141% YoY | β48% QoQ
β’ EBITDA: βΉ76 Cr vs Loss of βΉ74 Cr (YoY) | vs Loss of βΉ45 Cr (QoQ)
β’ EBITDA Margin: 9.2% vs -22.0% (YoY) | -8.1% (QoQ)
β’ Other Income: βΉ53 Cr
β’ EPS: βΉ4.76 | β243% YoY | β503% QoQ
β€1
BHARTI HEXACOM Q2 FY27 (STANDALONE) β GOOD β
β’ Net Profit: βΉ566 Cr | β34% YoY | β17% QoQ
β’ Revenue: βΉ2,582 Cr | β11% YoY | β3% QoQ
β’ EBITDA: βΉ1,377 Cr | β14% YoY | β4% QoQ
β’ EBITDA Margin: 53.3% vs 52.1% (YoY) | 52.7% (QoQ)
β’ Other Income: βΉ64 Cr
β’ EPS: βΉ11.32 | β34% YoY | β17% QoQ
β’ Net Profit: βΉ566 Cr | β34% YoY | β17% QoQ
β’ Revenue: βΉ2,582 Cr | β11% YoY | β3% QoQ
β’ EBITDA: βΉ1,377 Cr | β14% YoY | β4% QoQ
β’ EBITDA Margin: 53.3% vs 52.1% (YoY) | 52.7% (QoQ)
β’ Other Income: βΉ64 Cr
β’ EPS: βΉ11.32 | β34% YoY | β17% QoQ
GPT HEALTHCARE Q2 FY27 (STANDALONE) β GOOD β
β’ Net Profit: βΉ15 Cr | β45% YoY | β21% QoQ
β’ Revenue: βΉ136 Cr | β14% YoY | β7% QoQ
β’ EBITDA: βΉ27 Cr | β21% YoY | β11% QoQ
β’ EBITDA Margin: 19.8% vs 18.7% (YoY) | 19.2% (QoQ)
β’ Net Profit: βΉ15 Cr | β45% YoY | β21% QoQ
β’ Revenue: βΉ136 Cr | β14% YoY | β7% QoQ
β’ EBITDA: βΉ27 Cr | β21% YoY | β11% QoQ
β’ EBITDA Margin: 19.8% vs 18.7% (YoY) | 19.2% (QoQ)
HINDUSTAN CONSTRUCTION Q2 FY27 β WEAK β οΈ
β’ Net Profit: βΉ23 Cr | β53% YoY | β56% QoQ
β’ Revenue: βΉ897 Cr | β7% YoY | β10% QoQ
β’ EBITDA: βΉ103 Cr | β30% YoY | β2% QoQ
β’ EBITDA Margin: 11.5% vs 15.4% (YoY) | 10.5% (QoQ)
β’ Net Profit: βΉ23 Cr | β53% YoY | β56% QoQ
β’ Revenue: βΉ897 Cr | β7% YoY | β10% QoQ
β’ EBITDA: βΉ103 Cr | β30% YoY | β2% QoQ
β’ EBITDA Margin: 11.5% vs 15.4% (YoY) | 10.5% (QoQ)
INDIAN HUME PIPE Q2 FY27 (STANDALONE) β WEAK β οΈ
β’ Net Profit: βΉ22.75 Cr | β34.43% YoY | β3.48% QoQ
β’ Revenue: βΉ286.76 Cr | β21.39% YoY | β5.30% QoQ
β’ EBITDA: βΉ34.45 Cr | β33.17% YoY | β15.79% QoQ
β’ EBITDA Margin: 12.01% vs 14.13% (YoY) | 9.83% (QoQ)
β’ Net Profit: βΉ22.75 Cr | β34.43% YoY | β3.48% QoQ
β’ Revenue: βΉ286.76 Cr | β21.39% YoY | β5.30% QoQ
β’ EBITDA: βΉ34.45 Cr | β33.17% YoY | β15.79% QoQ
β’ EBITDA Margin: 12.01% vs 14.13% (YoY) | 9.83% (QoQ)
RAMCOCEM: Q2 CONS NET PROFIT 404.3M RUPEES VS 773.4M (YOY)
RAMCOCEM: Q2 EBITDA 3.26B RUPEES VS 3.88B (YOY); Q2 EBITDA MARGIN 13.25% VS 17.33% (YOY)
RAMCOCEM: Q2 REVENUE 24.63B RUPEES VS 22.39B (YOY)
RAMCOCEM: Q2 EBITDA 3.26B RUPEES VS 3.88B (YOY); Q2 EBITDA MARGIN 13.25% VS 17.33% (YOY)
RAMCOCEM: Q2 REVENUE 24.63B RUPEES VS 22.39B (YOY)
REPCOHOME: Q2 CONS NET PROFIT 1.12B RUPEES VS 1.03B (YOY)
REPCOHOME: Q2 EBITDA 4.16B RUPEES VS 3.9B (YOY); Q2 EBITDA MARGIN 87.23% VS 88.45% (YOY)
REPCOHOME: Q2 REVENUE 4.77B RUPEES VS 4.41B (YOY)
REPCOHOME: Q2 EBITDA 4.16B RUPEES VS 3.9B (YOY); Q2 EBITDA MARGIN 87.23% VS 88.45% (YOY)
REPCOHOME: Q2 REVENUE 4.77B RUPEES VS 4.41B (YOY)